Mobile

Efficacy of agomelatine (25 mg/day with potential adjustment to 50 mg) given orally on rest/activity circadian rhythms in outpatients with Major Depressive Disorder. A randomized, double-blind interna...

Mise à jour : Il y a 4 ans
Référence : EUCTR2004-004009-10

Efficacy of agomelatine (25 mg/day with potential adjustment to 50 mg) given orally on rest/activity circadian rhythms in outpatients with Major Depressive Disorder. A randomized, double-blind international study with parallel groups versus sertraline (50 mg/day with potential adjustment to 100 mg). Six-week treatment plus optional continuation for 18 weeks

Femme et Homme

  • | Pays :
    • -
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

To demonstrate that agomelatine (25/50 mg) improves rest/activity circadian rhythms faster than sertraline in outpatients suffering from Major Depressive Disorder.

Critère d'inclusion

  • Major Depressive Disorder

Liens